Cellebrite DI [CLBT] vs Klaviyo [KVYO] Detailed Stock Comparison
Cellebrite DI
NASDAQ
Loading...
Klaviyo
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Cellebrite DI wins in 5 metrics, Klaviyo wins in 13 metrics, with 0 ties. Klaviyo appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Cellebrite DI | Klaviyo | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 69.09 | -152.29 | Klaviyo |
| Price-to-Book Ratio | 11.14 | 7.07 | Klaviyo |
| Debt-to-Equity Ratio | 5.47 | 9.04 | Cellebrite DI |
| PEG Ratio | 46.55 | -0.44 | Klaviyo |
| EV/EBITDA | 55.04 | -76.00 | Klaviyo |
| Profit Margin (TTM) | -34.56% | -6.19% | Klaviyo |
| Operating Margin (TTM) | 14.58% | -10.69% | Cellebrite DI |
| EBITDA Margin (TTM) | 14.58% | N/A | N/A |
| Return on Equity | -81.98% | -6.42% | Klaviyo |
| Return on Assets (TTM) | 5.95% | -5.05% | Cellebrite DI |
| Free Cash Flow (TTM) | $121.56M | $148.73M | Klaviyo |
| 1-Year Return | 2.38% | -31.27% | Cellebrite DI |
| Price-to-Sales Ratio (TTM) | 10.42 | 7.20 | Klaviyo |
| Enterprise Value | $4.10B | $6.93B | Klaviyo |
| EV/Revenue Ratio | 9.39 | 6.43 | Klaviyo |
| Gross Profit Margin (TTM) | 84.39% | 75.70% | Cellebrite DI |
| Revenue per Share (TTM) | $2 | $4 | Klaviyo |
| Earnings per Share (Diluted) | $-0.72 | $-0.24 | Klaviyo |
| Beta (Stock Volatility) | 1.30 | 1.27 | Klaviyo |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Cellebrite DI vs Klaviyo Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Cellebrite DI | -1.62% | -0.22% | 8.19% | 21.25% | 3.07% | -14.64% |
| Klaviyo | -2.75% | -8.16% | -23.40% | -24.90% | -3.78% | -38.93% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Cellebrite DI | 2.38% | 333.02% | 91.41% | 91.41% | 91.41% | 91.41% |
| Klaviyo | -31.27% | -23.84% | -23.84% | -23.84% | -23.84% | -23.84% |
News Based Sentiment: Cellebrite DI vs Klaviyo
Cellebrite DI
News based Sentiment: MIXED
The month of October 2025 presented a mixed picture for Cellebrite, with positive analyst upgrades and a 'Conviction List' inclusion offset by some institutional selling and tempered price target revisions. The upcoming Q1 2024 earnings release on May 9, 2024, will be a key catalyst for investors to assess the company's performance and future prospects, particularly in light of its focus on AI and potential benefits from federal spending.
Klaviyo
News based Sentiment: POSITIVE
October 2025 brought a wave of positive analyst coverage, significant institutional investment, and a strategic product launch focused on AI, all pointing towards a strengthening investment case for Klaviyo. While insider selling is a minor concern, the overall narrative is decidedly bullish.
Performance & Financial Health Analysis: Cellebrite DI vs Klaviyo
| Metric | CLBT | KVYO |
|---|---|---|
| Market Information | ||
| Market Cap | $4.67B | $9.40B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,491,440 | 4,592,660 |
| 90 Day Avg. Volume | 1,759,980 | 2,953,277 |
| Last Close | $18.49 | $25.43 |
| 52 Week Range | $13.10 - $26.30 | $23.77 - $49.55 |
| % from 52W High | -29.70% | -48.68% |
| All-Time High | $26.30 (Feb 03, 2025) | $49.55 (Feb 10, 2025) |
| % from All-Time High | -29.70% | -48.68% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.18% | 0.32% |
| Quarterly Earnings Growth | 0.18% | 0.32% |
| Financial Health | ||
| Profit Margin (TTM) | -0.35% | -0.06% |
| Operating Margin (TTM) | 0.15% | -0.11% |
| Return on Equity (TTM) | -0.82% | -0.06% |
| Debt to Equity (MRQ) | 5.47 | 9.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.67 | $3.66 |
| Cash per Share (MRQ) | $1.93 | $3.12 |
| Operating Cash Flow (TTM) | $161.08M | $168.96M |
| Levered Free Cash Flow (TTM) | $122.92M | $186.32M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Cellebrite DI vs Klaviyo
| Metric | CLBT | KVYO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 69.09 | -152.29 |
| Forward P/E | 46.55 | 46.23 |
| PEG Ratio | 46.55 | -0.44 |
| Price to Sales (TTM) | 10.42 | 7.20 |
| Price to Book (MRQ) | 11.14 | 7.07 |
| Market Capitalization | ||
| Market Capitalization | $4.67B | $9.40B |
| Enterprise Value | $4.10B | $6.93B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.39 | 6.43 |
| Enterprise to EBITDA | 55.04 | -76.00 |
| Risk & Other Metrics | ||
| Beta | 1.30 | 1.27 |
| Book Value per Share (MRQ) | $1.67 | $3.66 |
Financial Statements Comparison: Cellebrite DI vs Klaviyo
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CLBT | KVYO |
|---|---|---|
| Revenue/Sales | $113.28M | $293.12M |
| Cost of Goods Sold | $17.68M | $71.24M |
| Gross Profit | $95.60M | $221.88M |
| Research & Development | $28.61M | $72.46M |
| Operating Income (EBIT) | $14.42M | $-31.33M |
| EBITDA | $17.01M | $-27.40M |
| Pre-Tax Income | $20.79M | $-22.48M |
| Income Tax | $1.32M | $1.80M |
| Net Income (Profit) | $19.48M | $-24.28M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CLBT | KVYO |
|---|---|---|
| Cash & Equivalents | $90.48M | $888.43M |
| Total Current Assets | $523.48M | $1.01B |
| Total Current Liabilities | $287.80M | $192.82M |
| Long-Term Debt | $6.39M | $84.12M |
| Total Shareholders Equity | $363.49M | $1.06B |
| Retained Earnings | $-147.46M | $-859.27M |
| Property, Plant & Equipment | $28.03M | $90.82M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CLBT | KVYO |
|---|---|---|
| Operating Cash Flow | $28.07M | $36.85M |
| Capital Expenditures | $-2.34M | $-2.69M |
| Free Cash Flow | $18.54M | $6.62M |
| Debt Repayment | N/A | $0 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CLBT | KVYO |
|---|---|---|
| Shares Short | 8.02M | 6.83M |
| Short Ratio | 3.58 | 3.67 |
| Short % of Float | 0.07% | 0.06% |
| Average Daily Volume (10 Day) | 1,491,440 | 4,592,660 |
| Average Daily Volume (90 Day) | 1,759,980 | 2,953,277 |
| Shares Outstanding | 234.52M | 272.76M |
| Float Shares | 112.43M | 115.43M |
| % Held by Insiders | 0.43% | 0.01% |
| % Held by Institutions | 0.50% | 0.89% |
Dividend Analysis & Yield Comparison: Cellebrite DI vs Klaviyo
| Metric | CLBT | KVYO |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |